RxDoctor Payments Data

Marika Walker, PA

Medical · Port Orange, FLNPI 1437469970

Payments from drug & device makers

$2,823in general payments, 2019–2025

Across 131 payments — averaging $21.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$575
  • AbbVie$464
  • Takeda Pharmaceuticals U.S.A., Inc.$331
  • QOL Medical, LLC$195
  • Gilead$173
  • Sanofi$142
  • plus $944 from 16 others

What the payments were for

  • Food & beverage$2,823100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,823 in reported general payments places this provider in the 75th percentile of 2,031 medical providers in Florida.

See all medical providers in Florida

Medicare billing

Part B allowed, 2024
$39,035
Medicare patients
289
Services billed
385

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
CreonLipase/Protease/Amylase15$72,234
LinzessLinaclotide27$23,426
PentasaMesalamine14$9,823
Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates111$7,140
ClenpiqSod Picosulf/Mag Ox/Citric Ac32$5,388
Ursodiol13$2,102
Omeprazole94$1,075
Pantoprazole Sodium67$1,024
Famotidine79$967
Dicyclomine Hcl25$534
Esomeprazole Magnesium15$488
Ondansetron OdtOndansetron14$255
Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl11$213
Lactulose14$182
Metronidazole19$139

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieCreon, Linzess$464$95,65942 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,031 medical providers in Florida.

Other medical in Port Orange

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →